These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 28863309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
    Pantazis P, Dimas K, Wyche JH, Anant S, Houchen CW, Panyam J, Ramanujam RP.
    Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM.
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [Abstract] [Full Text] [Related]

  • 10. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X, Zhu Q, Sun Y, Li L, Zhu Y, Zhao Z, Zuo J, Fang W, Li K.
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [Abstract] [Full Text] [Related]

  • 11. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
    Jagani HV, Josyula VR, Palanimuthu VR, Hariharapura RC, Gang SS.
    Eur J Pharm Sci; 2013 Mar 12; 48(4-5):611-8. PubMed ID: 23291045
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy.
    Ben-David-Naim M, Dagan A, Grad E, Aizik G, Nordling-David MM, Morss Clyne A, Granot Z, Golomb G.
    Cancers (Basel); 2019 Mar 29; 11(4):. PubMed ID: 30934857
    [Abstract] [Full Text] [Related]

  • 14. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
    Baishya R, Nayak DK, Kumar D, Sinha S, Gupta A, Ganguly S, Debnath MC.
    Pharm Res; 2016 Nov 29; 33(11):2691-703. PubMed ID: 27431865
    [Abstract] [Full Text] [Related]

  • 15. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY, Hong SH, Singh B, Islam MA, Lee S, Lee AY, Gankhuyag N, Kim JE, Yu KN, Kim KH, Park YC, Cho CS, Cho MH.
    Eur J Pharm Biopharm; 2015 Aug 29; 94():450-62. PubMed ID: 26141346
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A, Haddadi A, Hamdy S, Samuel J, El-Kadi AO, Uludağ H, Lavasanifar A.
    Mol Pharm; 2010 Oct 04; 7(5):1643-54. PubMed ID: 20804176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.
    Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.